Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quillivant XR in Adults with ASD and ADHD
NCT02096952Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- May 2014
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Massachusetts General Hospital. Started May 2014; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT02096952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02096952.